Raymond James & Associates’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$49.1M Buy
120,759
+5,981
+5% +$2.19M 0.03% 443
2024
Q2
$36.9M Sell
114,778
-1,861
-2% -$605K 0.02% 509
2024
Q1
$38.9M Sell
116,639
-24,051
-17% -$7.35M 0.03% 486
2023
Q4
$38.1M Sell
140,690
-16,173
-10% -$4M 0.03% 481
2023
Q3
$38.6M Sell
156,863
-2,488
-2% -$681K 0.03% 431
2023
Q2
$48.4M Sell
159,351
-13,024
-8% -$3.62M 0.04% 370
2023
Q1
$45.5M Buy
172,375
+2,067
+1% +$525K 0.04% 388
2022
Q4
$40.9M Sell
170,308
-9,190
-5% -$2.06M 0.04% 400
2022
Q3
$33M Sell
179,498
-3,299
-2% -$657K 0.03% 427
2022
Q2
$30.7M Buy
182,797
+43,567
+31% +$9.36M 0.03% 456
2022
Q1
$34.9M Sell
139,230
-1,204
-0.9% -$302K 0.03% 475
2021
Q4
$36.1M Sell
140,434
-7,220
-5% -$1.77M 0.03% 488
2021
Q3
$35.8M Buy
147,654
+14,112
+11% +$3.45M 0.03% 463
2021
Q2
$27.6M Buy
133,542
+41,104
+44% +$8.38M 0.03% 551
2021
Q1
$17.4M Buy
92,438
+18,166
+24% +$3.2M 0.02% 728
2020
Q4
$12.2M Sell
74,272
-23,176
-24% -$3.39M 0.01% 845
2020
Q3
$12.2M Sell
97,448
-2,101
-2% -$260K 0.02% 757
2020
Q2
$9.66M Buy
99,549
+29,046
+41% +$3.02M 0.01% 841
2020
Q1
$6.33M Buy
70,503
+12,143
+21% +$1.57M 0.01% 932
2019
Q4
$8.63M Sell
58,360
-1,665
-3% -$224K 0.01% 966
2019
Q3
$7.23M Sell
60,025
-3,330
-5% -$430K 0.01% 1030
2019
Q2
$8.56M Sell
63,355
-697
-1% -$88.1K 0.01% 935
2019
Q1
$8.35M Buy
64,052
+4,309
+7% +$579K 0.01% 907
2018
Q4
$7.43M Buy
59,743
+1,371
+2% +$184K 0.01% 897
2018
Q3
$8.12M Sell
58,372
-23,111
-28% -$2.88M 0.01% 950
2018
Q2
$8.36M Buy
81,483
+6,039
+8% +$611K 0.01% 913
2018
Q1
$7.32M Sell
75,444
-1,346
-2% -$131K 0.01% 945
2017
Q4
$6.75M Sell
76,790
-9,099
-11% -$731K 0.01% 966
2017
Q3
$6.84M Sell
85,889
-90,749
-51% -$7.3M 0.01% 932
2017
Q2
$15.4M Sell
176,638
-1,133
-0.6% -$95.9K 0.03% 531
2017
Q1
$15.8M Buy
177,771
+3,927
+2% +$327K 0.04% 488
2016
Q4
$12.9M Sell
173,844
-3,530
-2% -$264K 0.03% 528
2016
Q3
$13.4M Buy
177,374
+13,780
+8% +$1.06M 0.04% 483
2016
Q2
$12.6M Buy
163,594
+29,668
+22% +$2.34M 0.04% 462
2016
Q1
$10.5M Buy
133,926
+19,143
+17% +$1.34M 0.04% 511
2015
Q4
$7.76M Sell
114,783
-3,224
-3% -$225K 0.03% 625
2015
Q3
$9.13M Buy
118,007
+3,664
+3% +$324K 0.04% 519
2015
Q2
$10.4M Buy
114,343
+16,924
+17% +$1.36M 0.04% 508
2015
Q1
$7.33M Buy
97,419
+6,633
+7% +$476K 0.03% 574
2014
Q4
$6.66M Buy
90,786
+35,592
+64% +$2.5M 0.03% 556
2014
Q3
$3.89M Sell
55,194
-4,275
-7% -$283K 0.02% 746
2014
Q2
$3.35M Sell
59,469
-4,916
-8% -$259K 0.02% 825
2014
Q1
$3.38M Buy
64,385
+22,409
+53% +$1.12M 0.02% 749
2013
Q4
$2M Buy
41,976
+24,974
+147% +$1.15M 0.02% 964
2013
Q3
$727K Sell
17,002
-1,846
-10% -$72.1K 0.01% 1410
2013
Q2
$680K Buy
+18,848
New +$729K 0.01% 1356

Other funds holding HCA